Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 27Neoplasms 25Lung Neoplasms 12Uterine Cervical Neoplasms 11Colorectal Neoplasms 10Colonic Neoplasms 8Motor Activity 7Urinary Bladder Neoplasms 6Rectal Neoplasms 6Vulvar Neoplasms 5Obesity 5Endometrial Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Melanoma 4Head and Neck Neoplasms 4Anxiety Disorders 4Stomach Neoplasms 3Sarcoma 3Prostatic Neoplasms 3Papillomavirus Infections 3Lymphoma 3Hematopoietic and Lymphoid System Neoplasm 3Hematologic Neoplasms 3Depression 3Carcinoma, Ovarian Epithelial 3Breast Carcinoma In Situ 3Vaginal Neoplasms 2Testicular Neoplasms 2Smoking Cessation 2Skin Neoplasms 2

Interventions

relacorilant 4Resistance Training 3Pioglitazone 3Dipeptidyl-Peptidase IV Inhibitors 3Sulfonylurea Compounds 2Rosiglitazone 2Nutritional Status 2Metformin 2voglibose 1saxagliptin 1repaglinide 1pembrolizumab 1miglitol 1metahexamide 1meglitinide 1glymidine 1glisoxepide 1gliquidone 1glimepiride 1glibornuride 1empagliflozin 1Vildagliptin 1Troglitazone 1Tolbutamide 1Tolazamide 1Thiazolidinediones 1Surveys and Questionnaires 1Sodium-Glucose Transporter 2 Inhibitors 1Sitagliptin Phosphate 1Resistant Starch 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diabetes Mellitus, Type 2 × Methods × Clear all
NCT04938869 2023-02-24

Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
3 enrolled

Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡